Vol.79, No.5 May 2017
Explanation of the cover photograph
A study on the efficacy of the recombinant Yersinia adhesin A vaccine against yersiniosis in the early phase
Kosuke TSUGO et al. (pp. 855-863)
Assessment the effectiveness of rYadA vaccine. The graph shows the transition of the survival rate. The survival rate is significantly increased in the rYadA-administered group (100%; **, P=0.0044) and inactivated Y. ptb-administered group (60%; *, P=0.0121). On the other hand, the survival rate of the PBS-administered group is 0%.
This number is available on J-STAGE